Siwa Therapeutics
  • Home
  • Leadership
  • Science
    • Senescence
    • Diseases
  • Data
    • SIWA 318
    • Data
    • Other Products
  • Media
    • News
    • Videos
  • Partners
  • Contact

Month: January 2018

Home / 2018 / January
09Jan 2018 by siwa-admin-2017

Third Annual Healthspan Extension Policy and Regulation Workshop

Events
- Upcoming
Read More

Recent Posts

  • In the News: Forbes
  • SIWA Therapeutics: A New Supernova to Discover!
  • DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD
  • Third Annual Healthspan Extension Policy and Regulation Workshop
  • Second Annual Healthspan Extension Policy and Regulation Workshop

Archives

  • September 2019
  • March 2019
  • April 2018
  • January 2018
  • June 2017
  • May 2017
  • October 2016

Categories

  • Events
  • In The News
  • Press Releases

About Us

SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.

Recent News

  • In the News: Forbes
  • SIWA Therapeutics: A New Supernova to Discover!
  • DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD

JOIN OUR MAILING LIST

Navigation

  • Home
  • Leadership
  • Science
    • Senescence
    • Diseases
  • Data
    • SIWA 318
    • Data
    • Other Products
  • Media
    • News
    • Videos
  • Partners
  • Contact